These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23095418)

  • 1. Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the dialytrauma concept.
    Maynar Moliner J; Honore PM; Sánchez-Izquierdo Riera JA; Herrera Gutiérrez M; Spapen HD
    Blood Purif; 2012; 34(2):177-85. PubMed ID: 23095418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of continuous renal replacement therapy.
    Finkel KW; Podoll AS
    Semin Dial; 2009; 22(2):155-9. PubMed ID: 19426420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the benefits of early mobility to critically ill patients undergoing continuous renal replacement therapy: the Michigan experience.
    Talley CL; Wonnacott RO; Schuette JK; Jamieson J; Heung M
    Crit Care Nurs Q; 2013; 36(1):89-100. PubMed ID: 23221445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Renal Replacement Therapy for the Management of Acid-Base and Electrolyte Imbalances in Acute Kidney Injury.
    Yessayan L; Yee J; Frinak S; Szamosfalvi B
    Adv Chronic Kidney Dis; 2016 May; 23(3):203-10. PubMed ID: 27113697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and managing complications of renal replacement therapy in the critically ill.
    Selby NM; McIntyre CW
    Blood Purif; 2012; 34(2):171-6. PubMed ID: 23095417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical Complications of Continuous Renal Replacement Therapy.
    Ricci Z; Romagnoli S
    Contrib Nephrol; 2018; 194():99-108. PubMed ID: 29597221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management.
    Claure-Del Granado R; Bouchard J
    Blood Purif; 2012; 34(2):186-93. PubMed ID: 23095419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous renal replacement therapy in children: fluid overload does not always predict mortality.
    de Galasso L; Emma F; Picca S; Di Nardo M; Rossetti E; Guzzo I
    Pediatr Nephrol; 2016 Apr; 31(4):651-9. PubMed ID: 26563114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical considerations for the dosing and adjustment of continuous renal replacement therapy in the intensive care unit.
    Galvagno SM; Hong CM; Lissauer ME; Baker AK; Murthi SB; Herr DL; Stein DM
    J Crit Care; 2013 Dec; 28(6):1019-26. PubMed ID: 23890937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances.
    Kraus MA
    Semin Dial; 2009; 22(2):137-40. PubMed ID: 19426416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure.
    Chua HR; Baldwin I; Bailey M; Subramaniam A; Bellomo R
    J Crit Care; 2012 Dec; 27(6):744.e7-15. PubMed ID: 23102533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality measures for acute kidney injury and continuous renal replacement therapy.
    Rewa O; Mottes T; Bagshaw SM
    Curr Opin Crit Care; 2015 Dec; 21(6):490-9. PubMed ID: 26539922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid Management during Continuous Renal Replacement Therapy: A Case-Based Approach.
    Neyra JA; Mehta RL; Murugan R
    Nephron; 2023; 147(12):782-787. PubMed ID: 37793364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous renal replacement therapy: cause and treatment of electrolyte complications.
    Fall P; Szerlip HM
    Semin Dial; 2010; 23(6):581-5. PubMed ID: 21166876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic Impact of a slower pump speed at start of continuous renal replacement therapy in critically Ill adults with acute kidney injury: a prospective before-and-after study.
    Eastwood GM; Peck L; Young H; Bailey M; Reade MC; Baldwin I; Bellomo R
    Blood Purif; 2012; 33(1-3):52-8. PubMed ID: 22179304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry.
    Sutherland SM; Zappitelli M; Alexander SR; Chua AN; Brophy PD; Bunchman TE; Hackbarth R; Somers MJ; Baum M; Symons JM; Flores FX; Benfield M; Askenazi D; Chand D; Fortenberry JD; Mahan JD; McBryde K; Blowey D; Goldstein SL
    Am J Kidney Dis; 2010 Feb; 55(2):316-25. PubMed ID: 20042260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients.
    Connor MJ; Karakala N
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):213-218. PubMed ID: 28778360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.